Does VEDOLIZUMAB Cause Maternal exposure timing unspecified? 43 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Maternal exposure timing unspecified have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.1% of all adverse event reports for VEDOLIZUMAB.
43
Reports of Maternal exposure timing unspecified with VEDOLIZUMAB
0.1%
of all VEDOLIZUMAB reports
39
Deaths
41
Hospitalizations
How Dangerous Is Maternal exposure timing unspecified From VEDOLIZUMAB?
Of the 43 reports, 39 (90.7%) resulted in death, 41 (95.3%) required hospitalization, and 41 (95.3%) were considered life-threatening.
Is Maternal exposure timing unspecified Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 43 reports have been filed with the FAERS database.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Maternal exposure timing unspecified?
RITUXIMAB (402)
METHOTREXATE (350)
ADALIMUMAB (343)
DICLOFENAC (331)
TOCILIZUMAB (327)
HYDROXYCHLOROQUINE (309)
FOLIC ACID (304)
INFLIXIMAB (303)
LEFLUNOMIDE (302)
SECUKINUMAB (301)
Which VEDOLIZUMAB Alternatives Have Lower Maternal exposure timing unspecified Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB